The microcirculation during endotoxemia

Cardiovascular Research

Volumn 32, Issue 4, 1996, Pages 752-763

  McCuskey, Robert S ^a   Urbaschek, Renate ^b   Urbaschek, Bernhard ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endothelium; Endotoxins; Leukocytes; Macrophages; Microcirculation; Microvascular flow; Platelets

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTOXIN; ICOSANOID; NITRIC OXIDE; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; GUINEA PIG; HAMSTER; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; ENDOTOXINS; HEAT-SHOCK PROTEINS; HUMANS; MICROCIRCULATION; SHOCK, SEPTIC;

EID: 0030270654     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00113-7     Document Type: Review

References (158)

1. [1] Raetz CRH. Biochemistry of endotoxins, Annu Rev Biochem 1990;59:129-170.
2. [2] Nolan JP, Camara DS. Endotoxin, sinusoidal cells, and liver injury. Prog Liver Dis 1982;7:361-376.
3. [3] Nolan JP. Intestinal endotoxins as mediators of hepatic injury - an idea whose time has come again. Hepatology 1989;10:887-891.
4. [4] McCuskey RS, Nishida J, Eguchi H, et al. Role of endotoxin in the hepatic microvascular inflammatory response to ethanol. J Gastroenterol Hepatology 1995;10(suppl 1):518-523.
5. [5] Ruiter DJ, van der Maulen J, Brouwer A, et al. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 1981;45:38-45.
6. [6] Mathison JC, Ulevitch R. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979;123:2133-2143.
7. [7] Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol 1993;53:267-289.
8. [8] Noel RF, Sato TT, Mendez C, Johnson MC, Pohlman TH. Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14. Infect Immun 1995;63:4046-4053.
9. [9] Moore KL, Andreoli SP, Esmon NL, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human endothelium in vitro. J Clin Invest 1986;79:124-130.
10. [10] Gralnick HR, McKeown LP, Wilson OM, Williams SB, Elin RJ. Von Willebrand factor release induced by endotoxin. J Lab Clin Med 1989;113:118-121.
11. [11] Levi M, ten Cate H, van der Poll T, van Deventer SJ. Pathogenesis of disseminated intravascular coagulation in sepsis. J Am Med Assoc 1993;271:427-428.
12. [12] Urbaschek B, Urbaschek R, Neter E. Gram-Negative Bacterial Infections and Mode of Endotoxic Actions. Vienna: Springer-Verlag, 1975.
13. [13] Szentivanyi E, Nowotny A, Friedman H, eds. Immunobiology and Immunopharmacology of Bacterial Endotoxins. New York: Plenum Press, 1986.
14. [14] Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 1987;93:527-617.
15. [15] Morrison DC, Ryan JL. Bacterial Endotoxic Lipopolysaccharides. I. Molecular Biochemistry and Cellular Biology. Boca Raton, FL: CRC Press, 1992.
16. [16] Ryan JC, Morrison DC. Bacterial Endotoxic Lipopolysaccharides. II. Immunopharmacology and Pathophysiology. Boca Raton, FL: CRC Press, 1992.
17. [17] McMillen MA, Huribal M, Sumpio B. Common pathway of endothelial-leukocyte interaction in shock, ischemia, and reperfusion. Am J Surg 1993;166:557-562.
18. [18] Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-469.
19. [19] Giroir BP. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 1993;21:780-789.
20. [20] Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
21. [21] Kurose I, Suematsu M, Miura S, et al. Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery-attenuating effect of cetraxate. Toxicol Appl Pharmacol 1993;120:37-44.
22. [22] Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Biol 1994;55:662-675.
23. [23] Urbaschek B. The effects of endotoxins in the microcirculation. In: Kadis S, Weinbaum G, Ajl SJ, eds. Microbial Toxins, Vol V. New York: Academic Press, 1971:261-275.
24. [24] Urbaschek B, Urbaschek R. The inflammatory response to endotoxins. Bibl Anat 1979;17:74-104.
25. [25] Urbaschek B, Urbaschek R. Endotoxins and microvascular functions. Clin Hemorrheol 1982;2:295-303.
26. [26] Zweifach BW. Vascular effects of bacterial endotoxin. In: Landy M, Braun W, eds. Bacterial Endotoxins. New Brunswick. NJ: Rutgers University, 1964:110-117.
27. [27] Svensjo E, Erlansson M, van den Bos GC, Endotoxin-induced increase in leukocyte adherence and macromolecular permeability of postcapillary venules. Agents Actions 1990;29:21-23.
28. w-nitro-L-arginine and dexamethasone on early events following lipopolysaccharide injection: observations in the hamster cheek pouch microcirculation. Shock 1994;1:347-353.
29. [29] Paya D, Stoclet JC. Involvement of bradykinin and nitric oxide in the early hemodynamic effects of lipopolysaccharide in rats. Shock 1995;3:376-379.
30. [30] Spain DA, Wilson MA, Bar-Natan MF, Garrison RN. Role of nitric oxide in the small intestinal microcirculution during bacteremia. Shock 1994;2:41-46.
31. [31] Mollitt DL, Poulos ND. The role of pentoxifylline in endotoxin-induced alterations of red cell deformability and whole blood viscosity in the neonate. J Pediatr Surg 1991;26:572-574.
32. [32] Betticher DC, Keller H, Maly FE, Reinhart WH. The effect of endotoxin and tumour necrosis factor on erythrocyte and leukocyte deformability in vitro. Br J Haematol 1993;83:130-137.
33. [33] Todd JC, Poulos ND, Mollitt DL. The effect of endotoxin on the neonatal erythrocyte. J Pediatr Surg 1993;28:334-336;336-337(discussion).
34. [34] Todd JC, Poulos ND, Mollitt DL. The effect of endotoxin on neonatal erythrocyte intracellular calcium concentration. J Pediatr Surg 1994;29:805-807.
35. [35] Matsuda T, Rubinstein I, Robbins RA, Koyama S, Joyner WL, Rennard SI. Role of neutrophils in endotoxin-mediated microvascular injury in hamsters. J Appl Physiol 1991;71:307-313.
36. [36] Ookawa K, Sato M, Ohshima N. Emigration of activated leukocytes augments transvascular permeability in mesenteric venules of rat. In Vivo 1991;5:349-354.
37. [37] Yi ES, Ulich TR. Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules. Am J Pathol 1992;140:659-663.
38. [38] Urbaschek B, Fritsch H, Richter IE. Erste Beobachtungen mit dem Rasterelektronenmikroskop in der Frühphase der Endotoxin-wirkung an der terminalen Strombahn. Klin Wochenschr 1969;47:1166-1170.
39. [39] Urbaschek B, Forssmann WG, Urbaschek R. Endotoxin-induced microcirculatory disturbances. In: Grayson J, Zwingg W, eds. Microcirculation II. New York: Plenum Press, 1976:176-178.
40. [40] Urbaschek B, Versteyl R. Increase in the effect of histamine by E. coli endotoxin on the smooth muscle. Nature 1965;207:763-764.
41. [41] Vogt W, Damerau B, von Zabern I, Nolte R, Brunahl D. Non-enzymatic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product. C5b-like C5. Mol Immunol 1989;26:1133-1142.
42. [42] Lagente V, Fortes ZB, Garcia-Leme J, Vargaftig BB. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. J Pharmacol Exp Ther 1988;247:254-261.
43. [43] Miura S, Imaeda H, Shiozaki H, et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. Am J Physiol 1993;264:G828-G834.
44. [44] Klabunde RE, Calvello C. Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor. Shock 1995;4:368-372.
45. [45] Matuschak GM, Pinsky MR, Klein EC, Van Thiel DH, Rinaldo JE. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am Rev Respir Dis 1990;141:1296-1306.
46. [46] Meyrick B, Brigham KL. Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships. Lab Invest 1983;48:458-470.
47. [47] Welbourn CRB, Young Y. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 1992;79:998-1003.
48. [48] Morisaki T, Goya T, Toh H, Nishihara K, Torisu M. The anti Mac-1 monoclonal antibody inhibits neutrophil sequestration in lung and liver in a septic murine model. Clin Immunol Immunopathol 1991;61:365-175.
49. [49] Rabinovici R, Bugelski PJ, Esser KM. et al. Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. J Pharmacol Exp Ther 1993;267:1550-1557.
50. [50] Rabinovici R, Yen CG, Hillegass LM, et al. Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol 1992;149:1744-1750.
51. [51] Rabinovici R, Feuerstein G, Neville LF. Cytokine gene and peptide regulation in lung microvascular injury: new insights on the development of adult respiratory distress syndrome. Ann NY Acad Sci 1994;725:346-353.
52. 2. Am J Pathol 1993;142:367-373.
53. [53] McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170-182.
54. [54] Hansen J, Cherwitz DL, Allen JI. The role of tumor necrosis factor-α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology 1994;20:461-474.
55. [55] Decker K. Biologically active products of stimulated liver macrophages. Eur J Biochem 1990;192:245-361.
56. [56] Bautista AP, Deaciuc IV, Jaeschke H, Spolarics Z, Spitzer JJ. Hepatic responses to bacterial endotoxin (LPS). In: Schlag G, Redl H. eds. Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag, 1993;915-934.
57. [57] Bautista AP, Skrepnik N, Niesman MR, Bagby GJ. Elimination of macrophages by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-indueed priming of Kupffer cells. J Leukocyte Biol 1994;55:321-327.
58. [58] Nanji AA. Role of eicosanoids in experimental alcoholic liver disease. Alcohol 1993;10:443-446.
59. [59] Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. Endotoxin-indueed cytokine gene expression and excretion in the liver. Hepatology 1994;19:480-488.
60. 57B1/6 mice. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the Hepatic Sinusoid III. Leiden: Kupffer Cell Foundation, 1991:465-468.
61. [61] Eguchi H, McCuskey PA, McCuskey RS. Kupffer cell activity and hepatic microvascular events after acute ethanol ingestion in mice. Hepatology 1991;13:751-757.
62. [62] McCuskey RS. Responses of the hepatic sinusoid lining and microcirculation to combinations of endotoxin, cytokines and ethanol. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the Hepatic Sinusoid, III. Leiden: Kupffer Cell Foundation, 1991:1-5.
63. [63] McCuskey RS, Eguchi H, Nishida J, et al. Effects of ethanol and cocaine alone or in combination on hepatic sinusoids of mice and rats. In: Wisse E, Knook DL, eds. Cells of the Hepatic Sinusoid IV. Leiden: Kupffer Cell Foundation, 1993:376-380.
64. [64] Nishida J, McCuskey RS, McDonnell D, Fox ES. Protective role of nitric oxide in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994;30:G1135-G1141.
65. [65] Nishida J, Ekataksin W, McDonnell D, Urbaschek R, Urbaschek B, McCuskey RS. Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia and lethality in septic mice. Shock 1994;1:413-418.
66. [66] Nishida J, Baker GL, McCuskey RS. Protective role of nitric oxide in the TNFα mediated hepatic microvascular response following acute ethanol ingestion. Microcirculation 1995;2:108.
67. [67] Tiegs G. Immunotoxicology of host-response-mediated experimental liver injury. J Hepatol 1994;21:890-903.
68. [68] Spolarics Z, Spitzer JJ, Wang JF, Xie J, Kolls J, Greenberg S. Alcohol administration attenuates LPS-induced expression of inducible nitric oxide synthase in Kupffer and hepatic endothelial cells. Biochem Biophys Res Commun 1993;197:606-611.
69. [69] Kurose I, Kato S, Ishii H, Fukumura D, Miura S, Suematsu M, Tsuchiya M. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. Hepatology 1993;18:380-388.
70. [70] Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating TNF, IL-1 and IL-6 concentrations in chronic alcoholic patients. Hepatology 1991;13:267-276.
71. [71] Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995;3:56-62.
72. [72] Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989;169:1467-1472.
73. [73] Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-1774.
74. [74] Laskin DL, Heck DE, Feder LS, Gardner CR, Laskin JD. Regulation of nitric oxide production by hepatic macrophages and endothelial cells. In: Knook DL, Wisse E, eds. Cells of the Hepatic Sinusoid IV. Leiden: Kupffer Cell Foundation, 1993:26-28.
75. [75] Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
76. [76] Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:103-142.
77. [77] Hutcheson IR, Wittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity of endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1992;101:815-820.
78. [78] Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous mediator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
79. [79] Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
80. [80] Zhang P, Xie M, Spitzer JA. Hepatic neutrophil sequestration in early sepsis: enhanced expression of adhesion molecules and phagocytic activity. Shock 1994;2:133-140.
81. [81] Zhang JX, Jones DV, Clemens MG. Effect of activation on neutrophil-induced hepatic microvascular injury in isolated rat liver. Shock 1994;1:273-278.
82. [82] Marzi I, Bauer C, Hower R, Buhren V. Leukocyte-endothelial cell interactions in the liver after hemorrhagic shock in the rat. Circ Shock 1993;40:105-114.
83. [83] Marzi I, Buhren V, Schuttler A, Trentz O. Value of superoxide dismutase for prevention of multiple organ failure after multiple trauma. J Trauma 1993;35:110-120.
84. [84] Bauer M, Marzi I, Thuma B, Bach F, Buhren V, Larsen R. Dose-related pattern of sinusoidal leukocyte adhesion in sublobular regions of the liver after systemic endotoxin challenge in the rat. Shock 1994;1:135-140.
85. [85] Jaeschke H, Bautista AP, Sporlarics Z, Spitzer JJ. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukocyte Biol 992;52:377-382.
86. [86] Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 1993;264:G801-G809.
87. [87] Witthaut R, Farhood A, Smith CW, Jaeschke H. Complement and tumor necrosis factor-α contribute to Mac-1 (CD11b/CD18) upregulation and systemic neutrophil activation during endotoxemia in vivo. J Leukocyte Biol 1994;55:105-111.
88. [88] Hewett JA, Jean PA, Kunkel SL, Roth RA. Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am J Physiol 1993;265:G1011-G1015.
89. [89] Ochoa JB, Ukekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621-626.
90. [90] McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. In vivo microscopic studies of the responses of the liver to endotoxins. Klin Wochenschr 1982;60:749-751.
91. [91] Vollmar B, Glasz J, Senkel A, Menger MD, Messmer K. Role of leukocytes in the initial hepatic microvascular response to endotoxemia. Zbl Chir 1993;118:691-696.
92. [92] McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B. Species differences in Kupffer cells and endotoxin sensitivity. Infect Immun 1984;45:278-280.
93. [93] McCuskey RS, Urbaschek R, McCuskey PA, et al. Studies of Kupffer cells in mice sensitized or tolerant to endotoxin. In: Knook KL, Wisse E, eds. Sinusoidal Liver Cells. Amsterdam: Elsevier/North-Holland, 1982:387-392.
94. [94] LeBail B, Bioulac-Sage P, Senuita R, Quinton A, Saric J. Ballabaud C. Fine structure of hepatic sinusoids and sinusoidal cells in disease. J Electr Micro Tech 1990;14:257-282.
95. [95] McCuskey RS, Urbaschek R, McCuskey PA, et al. Deficient hepatic phagocytosis and lysosomal enzymes in the low endotoxin-responder, C3H/HeJ mouse. J Leukocyte Biol 1984;36:591-600.
96. [96] McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. In vivo microscopic observations of the responses of Kupffer cells and the hepatic microcirculation to Mycobacterium bovis BCG alone and in combination with endotoxin. Infect Immun 1983;42:362-367.
97. [97] McCuskey RS. Hepatic microvascular dysfunction during sepsis and endotoxemia. In: Tsuchiya M, ed. Cytoprotection and Cytobiology III. Amsterdam: Excerpta Medica, 1986:3-17.
98. [98] Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-460.
99. [99] Adachi Y, Moore LE, Bradford BU, Goa W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-224.
100. [100] McCuskey RS, Vonnahme FJ, Grun M. In vivo microscopic and electron microscopic observations of the hepatic microvascular system following portacaval anastomosis. Hepatology 1983;3:96-104.
101. [101] McCuskey RS, McCuskey PA, Gendrault J-L, et al. In vivo and electron microscopic study of dynamic events in hepatic sinusoids following Frog Virus 3 infection. In: Kirn A, Knook DL, Wisse E, eds. Cells of the Hepatic Sinusoid. Leiden: Kupffer Cell Foundation, 1986:351-356.
102. [102] McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. Hepatic microvascular responses to tumor necrosis factor. In: Wisse E, Knook DL, Decker K, eds. Cells of the Hepatic Sinusoids, II. Leiden: Kupffer Cell Foundation, 1989:272-276.
103. [103] Tracy JJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
104. [104] McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B. Kupffer cell function in host defense. Rev Infect Dis 1987;5:S616-S619.
105. [105] Reilly FD, Dimlich RVW, Cilento EV, McCuskey RS. Hepatic microvascular regulatory mechanisms. III. Aminergic mechanisms as related to mast cells. Microcirc Clin Exp 1983;2:61-73.
106. [106] Reilly FD, Dimlich RV. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCI on early hemodynamic and glucoregulatory alterations evoked by endotoxin. Microcirc Endothel Lymph 1985;2:271-292.
107. [107] Reilly FD, McCafferty RE, Cilento EV. Hepatic microvascular regulatory mechanisms. X. Effects of alpha-one or -two adrenoreceptor blockade on glucoregulation in normotensive endotoxic rats with optimal perfusion and flowrates. Microcirc Endothel Lymph 1988;4:293-309.
108. [108] Unger LS, Reilly FD. Hepatic microvascular regulatory mechanisms. VII. Effects of endoportally-infused endotoxin on microcirculation and mast cells in rats. Microcirc Endothel Lymph 1986;3:47-74.
109. [109] Unger LS, Reilly FD. Hepatic microvascular regulatory mechanisms, IX. Effects of compound 48/80 on endotoxin-induced changes in microcirculation and mast cell integrity. Microcirc Endothel Lymph 1986;3:109-128.
110. [110] Honchel R, Ray NB, Marsano L, et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 1992;16:665-669.
111. [111] Nanji AA, Sadrzadeh SMH, Thomas P, Yamanaka T. Eicosanoid profile and evidence for endotoxin tolerance in chronic ethanol-fed rats. Life Sci 1994;55:611-620.
112. [112] Urbaschek R, Urbaschek B, McCuskey PA, McCuskey RS. Die Bedeutung des reticuloendothelialen Systems im Endotoxin-Schock. Anaesthesist 1986;35:442-443.
113. [113] Urbaschek B. Perspectives on Bacterial Pathogenesis and Host Defense. Rev Infect Dis 1987;9:S431-659.
114. [114] Urbaschek R, Urbaschek B. Aspects of beneficial endotoxin-mediated effects. Klin Wochenschr 1982;60:746-748.
115. [115] Urbaschek B, Ditler B, Becker KP, Urbaschek R. Protective effects and role of endotoxin on experimental septicemia. Circ Shock 1984;14:209-222.
116. [116] Adams HR, Parker JL, Laughlin HM. Intrinsic myocardial dysfunction during endotoxemia: dependent or independent of myocardial ischemia? Circ Shock 1990;30:63-76.
117. [117] Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation 1986;73:637-644.
118. [118] Avontuur JAM, Bruining HA, Ince C. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995;76:418-425.
119. [119] Finkel MS, Oddis CV, Jacob TD, Watkirs SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
120. [120] Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992;263:H1963-H1966.
121. [121] Keller RS, Jones JJ, Kim KF, Myers PR, Adams HR, Parker JL, Rubin LJ. Endotoxin-induced myocardial dysfunction: is there a role for nitric oxide? Shock 1995;4:338-344.
122. [122] Moncada S, Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med 1993;30:2002-2012.
123. [123] Baker CH, Wilmoth FR. Microvascular responses to E. coli endotoxin with altered adrenergic activity. Circ Shock 1984;12:165-176.
124. [124] Baker CH, Sutton ET, Zhou Z, Reynolds DG. Reduced microvascular adrenergic receptor activity due to opioids in endotoxin shock. Circ Shock 1990;32:101-112.
125. [125] Parratt JR. Myocardial and circulatory effects of E. coli endotoxin modification of responses to catecholamines. Br J Pharmacol 1973;47:12-25.
126. [126] Sellke FW, Wang SY, Van der Meer TJ, Fink MP. Escherichia coli endotoxemia alters coronary and pulmonary arteriolar responses to platelet products. Shock 1994;1:279-285.
127. [127] Wang SY, Van der Meer TJ, Fink MP, Sellke FW. Uncoupling of coronary microvascular beta 2-adrenoceptors by Escherichia coli endotoxemia. Surgery 1994;116:307-312.
128. [128] Baker CH, Sutton ET, Zhou Z, Dietz JR. Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock 1990;30:81-95.
129. [129] Baker CH, Sutton ET. Modification of vasopressin microvascular responses by endotoxin, endothelin, and nitric oxide. Circ Shock 1994;42:59-67.
130. [130] Baker CH, Sutton ET. Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol 1993;264:H1118-H1123.
131. [131] Parker JL, Myers PR, Zhong Q, Kim K, Adams HR. Inhibition of endothelium-dependent vasodilation by Escherichia coli endotoxemia. Shock 1994;2:451-458.
132. [132] Myers PR, Parker JL, Tanner MA, Adams HR. Effects of cytokines tumor necrosis factor a and interleukin 1b on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium. Shock 1994;1:73-78.
133. [133] Zhang YH, Takahashi K, Jiang GZ, et al. In vivo production of heat shock protein in mouse peritoneal macrophages by administration of lipopolysaccharide. Infect Immun 1994;62:4140-4144.
134. [134] Retzlaff C, Yamamoto Y, Hoffman PS, Friedman H, Klein TW. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun 1994;62:5689-5693.
135. [135] Young RA, Elliott TJ. Stress proteins and immunology. Annu Rev Immunol 1990;8:401-420.
136. [136] Jaattala M, Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self protection. J Exp Med 1993;177:231-236.
137. [137] Donnelly TJ, Sievens FL, Vissern VJ, Welch WJ, Wolfe CL. Heat shock protein induction in rat hearts: a role for improved myocardial salvage after ischemia and reperfusion. Circulation 1992;85:769-778.
138. [138] Jacquier-Sarlin MR, Fuller K, Dinh-Xuan AT, Richard MJ, Polla BS. Protective effects of hsp70 in inflammation. Experientia 1994;50:1031-1038.
139. [139] Beeson PB. Development of tolerance to typhoid pyrogen and its abolition by reticuloendothelial blockade. Proc Soc Exp Biol Med 1946;61:248-250.
140. [140] Greisman SE. Induction of endotoxin tolerance. In: Nowotny A, ed. Beneficial Effects of Endotoxins. New York: Plenum Press, 1983:149-178.
141. [141] Cavaillon J-M. The nonspecific nature of endotoxin tolerance. Trends Immunol 1995;3:320-324.
142. [142] Urbaschek B, Urbaschek R. Some aspects of microcirculatory and metabolic changes in endotoxemia and endotoxin tolerance. In: Schlessinger D, ed. Microbiology-1977, Washington, DC: American Society for Microbiology, 1977:286-292.
143. [143] Urbaschek B, Branemark PI, Nowotny A. Lack of endotoxin effect on the microcirculation after pretreatment with detoxified endotoxin (endotoxoid). Experientia 1968;24:170-171.
144. [144] Barroso-Aranda J, Schmid-Schoenbein GW, Zweifach BW, Mathison JC. Polymorphonuclear neutrophil contribution to induced tolerance to bacterial lipopolysaccharide. Circ Res 1991;69:1196-1206.
145. [145] Urbaschek R, Mannel DN, Mergenhagen SE, Urbaschek B. The role of post-endotoxin serum components from BCG infected mice in the protection of compromised hosts. In: Szentivanyi E, Nowotny A, Friedman H, eds. Immunobiology and Immunopharmacology of Bacterial Endotoxins. New York: Plenum Press, 1983:221-231.
146. [146] Mengozzi M, Ghezzi P. Cytokine downregulation in endotoxin tolerance. Eur Cytokine Net 1993;4:96-98.
147. [147] Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg 1989;124:1432-1436.
148. [148] Dinarello CA, Wolff SM. Pathogenesis of fever in man. N Engl J Med 1978;298:607-612.
149. [149] Li MH, Scatter SC, Manthei R, Bubrick M, West MA. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res 1994;57:85-92.
150. [150] Urbaschek R, Urbaschek B. Tumor necrosis factor and interleukin-1 as mediators of endotoxin-induced beneficial effects. Rev Infect Dis 1987;9:S607-615.
151. [151] Moore JN, Cook JA, Morris DD, Halushka PV, Wise WC. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan. Circ Shock 1990;31:281-295.
152. [152] Zingarelli B, Halushka PV, Caputi AP, Cook JA. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 1995;3:102-108.
153. [153] Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 1995;3:2-32.
154. [154] Brown JM, Grosso MA, Tereda LS, et al. Endotoxin pretreatment increases endogenous myocardial catalase and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Nat Acad Sci USA 1989;86:2516-2520.
155. [155] Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in acute inflammatory response. J Biol Chem 1990;265:2856-2864.
156. [156] Shiki Y, Meyrick BO, Brigham KL, Burr IM. Endotoxin increases superoxide dismutase in cultured pulmonary endothelial cells. Am J Physiol 1987;252:C436-C440.
157. [157] Urbaschek B, Nowotny A. Endotoxin tolerance induced by detoxified endotoxin (endotoxoid). Proc Soc Exp Biol Med 1968;127:650-652.
158. [158] Carswell WA, Old JL, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.